Press Release
May 13, 2024

Goodwin advises Templewater on Multiple Healthcare Acquisitions

The Hong Kong Private Equity group led a cross-office Goodwin team on advising Templewater and its portfolio company TW Pengu Holdings Limited (“TWPHL”), on their acquisitions of:

  • Singapore Breast Surgery Center, an integrated breast cancer care group in Singapore, through its brands Solis and Luma, covering the entire breast cancer theragnostic process including screening, diagnostic imaging, pathology and surgery services;
  • Central Luzon Integrated Oncology Centre, a leading oncology clinic located in Mother Teresa of Calcutta Medical Center in San Fernando, Philippines, providing tomotherapy and chemotherapy services; and
  • Can-Care, a retailer and distributor of post-cancer care products, operating out of four retail outlets in Singapore and Malaysia as well as 22 distributor outlets.

TWPHL’s objective is to develop a premier oncology group in Asia to attract leading doctors and practices across multiple jurisdictions to enable patients to receive the best treatment and services across all stages of the treatment journey. With Templewater’s support, it has expanded its portfolio to include well-known oncology businesses that provide the highest standards of patient service.

In December 2023, TWPHL was set up following the acquisition of OncoCare, one of the most established private oncology specialist centers in Singapore, and Novena Heart Centre, one of the leading private cardiology care practices in Singapore. The Goodwin Hong Kong team advised on the acquisitions.

Templewater is an alternative asset management firm headquartered in Hong Kong. Templewater provides investment solutions to institutions, entrepreneurs, and family offices across various asset classes including private equity, impact investing, and real estate. Its private equity strategy focuses on mid-market control buyout opportunities in the Asia Pacific.

The Goodwin team was led by Edwin Chan and included Elena Yeung, Samson Peng and Billy Chong, with support from Steve Howard, Dora Cheung (Debt Finance), David Chen (Life Sciences/Privacy/IP), Dulcie Daly and Amy Francis (Tax), Ce “Charles” Li (Global Trade), William Stern (Financial Services) and Ai Tajima (Risk Management & Insurance).

For more details on the investment, please read the press release.